EKSO BIONICS HOLDINGS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Ekso Bionics Holdings, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2013 to Q4 2023.
  • Ekso Bionics Holdings, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $58.3M, a 7.91% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $58.3M +$4.27M +7.91% Dec 31, 2023 10-K 2024-03-04
Q4 2022 $54M +$740K +1.39% Dec 31, 2022 10-K 2024-03-04
Q4 2021 $53.3M +$4.59M +9.42% Dec 31, 2021 10-K 2023-03-28
Q4 2020 $48.7M +$3.19M +7.02% Dec 31, 2020 10-K 2022-02-24
Q4 2019 $45.5M +$3.9M +9.38% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $41.6M +$5.61M +15.6% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $36M -$4.15M -10.3% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $40.1M +$10.8M +37% Dec 31, 2016 10-K 2018-03-13
Q4 2015 $29.3M +$7.98M +37.5% Dec 31, 2015 10-K 2017-03-15
Q4 2014 $21.3M +$6.37M +42.6% Dec 31, 2014 10-K 2016-03-14
Q4 2013 $14.9M Dec 31, 2013 10-K 2015-03-19
Q3 2013 $14.2K* Sep 30, 2013 10-Q/A 2013-11-18
Q1 2013 $5.76K* Mar 31, 2013 10-Q 2014-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.